Acute heart infarction: Epidemiology and prehospital phase;Akuter herzinfarkt: Epidemiologie und prähospitalphase

Internist

Volumn 42, Issue 5, 2001, Pages 649-658

  Hombach, Vinzenz ^a   Koenig, W ^b   Kochs, M ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AJMALINE; ATROPINE; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; HEPARIN; LIDOCAINE; METOPROLOL; MORPHINE;

ACUTE HEART INFARCTION; ADULT; AGED; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREVALENCE; REVIEW; THROMBOSIS; TREATMENT INDICATION;

AGE DISTRIBUTION; ANTICOAGULANTS; ASPIRIN; EMERGENCY MEDICAL SERVICES; EUROPE; HEPARIN; HUMANS; INCIDENCE; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SEX DISTRIBUTION; THROMBOLYTIC THERAPY; TRANSPORTATION OF PATIENTS; UNITED STATES;

EID: 0343844288     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050806     Document Type: Review

References (27)

1. 1. Statistisches Bundesamt Gesundheitswesen (1997) Fachserie 12, Reihe 4, Todesursachen. Statistisches Bundesamt, Wiesbaden
2. 2. Lǒwel H, Engel S, Hörmann A et al. (1999) Akuter Herzinfarkt und plötzlicher Herztod aus epidemiologischer Sicht. Intensivmedizin 36: 652-661
3. 3. Lloyd-Jones D, Larson MG, Beiser A, Levy D (1999) Lifetime risk of developing coronary heart disease Lancet 353: 89-92
4. 4. WHO MONICA Project, Tunstall-Pedoe H, Kuulasmaa K, Amoyel P et al. (1994) Myocardial infarction and coronary deaths in the World Health Organisation MONICA Project. Circulation 90: 583-612
5. 5. Koenig W (1998) Epidemiologie der Koronaren Herzkrankheit, Z Kardiol 87 (Suppl 2): 3-7
6. 6. Lǒwel H, Lewis M, Hörmann A (1991 ) Prognostische Bedeutung der Prähospitalphase beim akuten Myokardinfarkt. Dtsch Med Wochenschr 16: 929-933
7. 7. Chambless L, Keil U, Dobson A et al. (1997) Population versus clinical view of case fatality from acute coronary heart disease. Results from the WHO MONICA Project 1985-1990. Circulation 96: 3849-3859
8. 8. Hunink MGM, Goldman L, Tosteson ANA et al. (1997) The recent decline in mortality from coronary heart disease 1980-1990. The effect of secular trends in risk factors and treatment. JAMA 277: 535-542
9. 9. Sans S, Kesteloot H, Kromhout D (1997) The burden of cardiovasculr diseases mortality in Europe.Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 18: 1231-1248
10. 10. Mc Govern, Pankow JS, Shahar E et al. (1996) Recent trends in acute coronary heart disease. Mortality, morbidity, medical care, and risk factors. N Engl J Med 334: 884-890
11. 11. Widdershoven JWWG, Gorgels APM, Vermeer F et al. (1997) Changing characteristics and inhospital outcome in patients admitted with acute myocardial infarction. Observations from 1982 to 1997. Eur Heart J 18: 1073-1080
12. 12. Kuulasmaa K, Tunstall-Pedoe H, Dobson A et al. (2000) Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355: 657-687
13. 13. Tunstall-Pedoe H, Vanuzzo D, Hobbs M et al. (2000) Estimation of contribution of changes in coronary care to improving survival, event rate, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 355: 688-700
14. 14. EUROASPIRE Study Group (1997) EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. Eur Heart J 18: 1569-1582
15. 15. Deutsche Gesellschaft für Kardiologie-Herzund Kreislaufforschung, Arntz HR, Tebbe U, Schuster HP et al. (2000) Leitlinien zur Diagnostik und Therapie des akuten Herzinfarktes in der Prǎhospitalphase. Z Kardiol 89: 364-372
16. 16. Risenfors M, Herlitz J, Berg CH et al. (1991) Early treatment with thrombolysis and betablockade in suspected acute myocardial infarction: results from the TEAHAT Study. J Intern Med Suppl 734: 35-42
17. 17. ISIS-2 (Second International Study of infarct Survival) Collaborative Group (1992) Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17.187 cases of suspected acute myocardial infarction: ISIS-2, Lancet II: 349-360
18. 18. Gaillet R, Sauer H, Pfister R, Pirovino M (1998) Welche Thrombolyserate kann bei akutem Myokardinfarkt realisiert werden? Ergebnisse der Oltner Herznotfailstudie. Schweiz Med Wochenschr 128: 775-783
19. 19. Boersma E, Maas ACP, Deckers JW, Simoons ML (1996) Early thrombolytic treatment in acute myocardial infarction; reappraisal of the golden hour. Lancet 348: 771-775
20. 20. Fibrinolytic Therapy Trialists' Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity of all randomized trials of more than 1000 patients. Lancet 343: 311-322
21. 21. The European Myocardial Infarction Project Group (1993) Prehospital thrombolysis therapy in patients with suspected acute myocardial infarction. N Engl J Med 329: 383-389
22. 22. Fath-Ordoubadi F, Al Mohammad A, Huehns TY, Beatt KJ (1994) Meta-analysis of randomised trials of prehospital versus hospital thrombolysis. Circulation 90: 1-325
23. 23. Rawles JM (1997) Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 30: 1181-1186
24. 24. Weaver WD, Simes RJ, Betrin A et al. (1997) Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 278: 2093-2098
25. 25. Hine LK, Laird N, Hewitt P, Chalmers TC (1989) Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 149: 2694-2698
26. 26. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study Mahon S, Collins R, Petro R et al. (1988) Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized controlled trials. JAMA 260: 1910-1916
27. 27. Teo KK, Yusuf S, Furberg SD (1993) Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 270: 1589-1595